Hyperglycemia during the Immediate Period after Kidney Transplantation
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVES: Hyperglycemia and new-onset diabetes occurs frequently after kidney transplantation. The stress of surgery and exposure to immunosuppression medications have metabolic effects and can cause or worsen preexisting hyperglycemia. To our knowledge, hyperglycemia in the immediate posttransplantation period has not been studied. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a retrospective, observational study to characterize the prevalence and assess the pharmacologic management of hyperglycemia in kidney transplant recipients who underwent transplantation at our center between June 1999 and December 2006. Data were abstracted from electronic and pharmacy databases. RESULTS: The study cohort included 424 patients (mean age 51 yr; 58% men; 25% with pretransplantation diabetes). All patients with and 87% without pretransplantation diabetes had evidence of hyperglycemia (bedside glucose >or=200 mg/dl or physician-instituted insulin therapy), whereas the prevalence of hypoglycemia was low (4.5%). Hyperglycemia was sustained throughout hospitalization. All patients with and 66% without pretransplantation diabetes required insulin at hospital discharge. Patients with pretransplantation diabetes were treated primarily with short-acting insulin during the first 24 h after transplantation but were transitioned to long-acting insulin as the hospital stay progressed. CONCLUSIONS: Investigators have historically attempted to identify hyperglycemia after hospital discharge. Our data indicate that a substantial number of patients without pretransplantation diabetes develop hyperglycemia and require insulin during the hospital phase of their care immediately after kidney transplantation. Prospective studies are needed to delineate factors that contribute to development of new-onset diabetes after transplantation among patients with transient hyperglycemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In most cases, such stressor steroidinduced hyperglycemia resolves by the time of discharge (142,143).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [143]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Whereas posttransplantation hyperglycemia is an important risk factor for subsequent PTDM, a formal diagnosis of PTDM is optimally made once the individual is stable on maintenance immunosuppression (usually at least 45 days after transplantation) and in the absence of acute infection (138,142 -144,147).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [143]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Whereas posttransplantation hyperglycemia is an important risk factor for subsequent PTDM, a formal diagnosis of PTDM is optimally made once the individual is stable on maintenance immunosuppression (usually at least 45 days) and in the absence of acute infection (138,(142)(143)(144)147).”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [143]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Diabetes Mellitus after Kidney Transplantation in the United States
Kasiske, B. L., Snyder, J. J., Gilbertson, D., & Matas, A. J. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00010.x · Cited by 1,285
Management of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266
Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation
Fioretto, P., Steffes, M. W., Sutherland, D. E. R., Goetz, F. C., & Mauer, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807093390202 · Cited by 1,135
NEW-ONSET DIABETES AFTER TRANSPLANTATION: 2003 INTERNATIONAL CONSENSUS GUIDELINES1
Davidson, J., Wilkinson, A., Dantal, J., Dotta, F., Haller, H., Hernandez, D., Kasiske, B. L., Kiberd, B., Krentz, A., Legendre, C., et al. (2003) · Transplantation · doi:10.1097/01.tp.0000069952.49242.3e · Cited by 676
Umpierrez, G. E., Smiley, D., Zisman, A., Prieto, L. M., Palacio, A., Ceron, M., Puig, A., & Mejia, R. (2007) · Diabetes Care · doi:10.2337/dc07-0295 · Cited by 671
Montori, V. M., Basu, A., Erwin, P. J., Velosa, J. A., Gabriel, S. E., & Kudva, Y. C. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.583 · Cited by 528
Association, A. D. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.775 · Cited by 464
Relationship of Early Hyperglycemia to Mortality in Trauma Patients
Laird, A. M., Miller, P. R., Kilgo, P. D., Meredith, J. W., & Chang, M. C. (2004) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/01.ta.0000123267.39011.9f · Cited by 457
American College of Endocrinology Position Statement on Inpatient Diabetes and Metabolic Control
Garber, A. J., Moghissi, E. S., Bransome, E. D., Clark, N. G., Clement, S., Cobin, R. H., Furnary, A. P., Hirsch, I. B., Levy, P., Roberts, R., et al. (2004) · Endocrine Practice · doi:10.4158/ep.10.s2.4 · Cited by 409
Research works printed but not linked: 2
- [14]Chakkera H, Weil J, Khan A, Cook C, Mazur M, Mulligan D, Reddy S, Moss A, McKeel K, Heilman R: Early post-transplant hyperglycemia is predictive of the development of new onset diabetes mellitus in kidney transplant recipients [Abstract]. Am J Transplant 7[Suppl 2]: 462, 2007 [Google Scholar]
- [24]Joint Commission on Accreditation of Healthcare Organizations: Inpatient Diabetes Certification. Available at: http://www.jointcommission.org/CertificationPrograms/Inpatient+Diabetes/. Accessed February 7, 2007 [PubMed]
Cited by
Items 101–133 of 133
Diabetes Mellitus and Renal Transplantation
Cook, C. B., & Chakkera, H. A. (2019) · Springer eBooks · doi:10.1007/978-3-319-97765-2_6 · Cited by 1
Self-citationDiabètes post-transplantation rénale
Dubois‐Laforgue, D. (2017) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2017.01.011 · Cited by 1
New-onset diabetes after transplantation: focus on strategies to reduce risk
Sharif, A. (2011) · Diabetes Management · doi:10.2217/dmt.11.10 · Cited by 1
Jeddi, M., Aghasadeghi, F., Omrani, G. R., Malek‐Hosseini, S. A., & Lakarani, K. B. (2019) · Experimental and Clinical Transplantation · doi:10.6002/ect.2019.0158 · Cited by 1
Zelada, H., VanWagner, L. B., Pollack, T., Higginbotham, D., Zhao, L., Yang, A., Molitch, M. E., & Wallia, A. (2018) · Transplantation Direct · doi:10.1097/txd.0000000000000830 · Cited by 1
Transplante Renal no Adulto: Fatores que influenciam a Sobrevida do Recetor e do Aloenxerto
Amaral, S. P. F. D. (2024) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/jayz-a223 · Cited by 1
The Effect of the GekoTM Device on Post Kidney and Pancreatic Transplantation Leg Edema
Alharbi, B. (2016) · Scholarship@Western (Western University) · Cited by 1
Kurnikowski, A., Salvatori, B., Krebs, M., Budde, K., Eller, K., Pascual, J., Morettini, M., Göbl, C. S., Hecking, M., & Tura, A. (2024) · Biomedicines · doi:10.3390/biomedicines12020317
Metabolic and Endocrine Management of the Organ Transplant Recipient
Issa, N. S., Reule, S. A., & Kukla, A. (2014) · Wiley eBooks · doi:10.1002/9781118873434.ch100
Post Transplantation Diabetes Mellitus
Lamacchia, O. (2023) · The Journal of AMD · doi:10.36171/jamd23.26.2.6
Ali, S. (2020) · American Diabetes Association eBooks · doi:10.2337/9781580406314.ch01
Посттрансплантационный сахарный диабет. Обзор литературы
Шамхалова, М. Ш., Shestakova, M. V., & Sechenov, I. M. (2015)
Patient after kidney transplantation in outpatient internal clinic
Roháľ, T. (2020) · Vnitřní lékařství · doi:10.36290/vnl.2020.075
Risk-Based Strategies for Population Screening and Disease Management
Munshi, V. N. (2020) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Incidence and Risk Factors for the Development of New-Onset Diabetes after Kidney Transplantation
Elamouri, J. S. (2023) · Journal of Diabetes and Endocrine Practice · doi:10.1055/s-0043-1763275
Mortality and cardiovascular events in new onset diabetes mellitus after renal transplantation
Lima, J. J. G. D., Gowdak, L. H. W., Reusing, J. O., David-Neto, E., & Bortolotto, L. A. (2025) · Canadian Journal of General Internal Medicine · doi:10.3138/cjgim.2025.0004
Guo, J., Qin, M., Li, J., Zhou, J., Qiu, T., & Tang, Y. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1557599
Bangash, W. G., Khokhar, S. Z., Maqsood, A., Rehman, H. U., Mahar, F. A., & Channa, A. A. (2021) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2023173388
Exploring the Benefits of Digital Health Technologies in Diabetes Management
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-8238-1
Suhecka, K., Lejnieks, A., Jushinskis, J., Maļcevs, A., Suhorukovs, V., Amerika, D., Straupmane, D., Pētersons, A., & Ziediņa, I. (2021) · Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences · doi:10.2478/prolas-2021-0016
Petkovska, L., Simonovska, N., Babulovska, A., Berat-Huseini, A., Kavrakova, J. B., Petronijevik, Z., & Ivanovska, B. Z. (2022) · Journal of Morphological Sciences · doi:10.55302/jms2253035p
Post-transplantasjons-diabetes mellitus i nyretransplanterte pasienter: En bihormonell sykdom
Egeland, E. J. (2015) · NVA (Nasjonalt vitenarkiv)
Yang, X., Li, Z., Cai, Q., Cui, Y., Deng, H., Xu, W., Peng, W., Wang, R., Huang, H., Chen, J., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1894397/v1
Nghiên cứu tỷ lệ và một số yếu tố liên quan đến tăng glucose máu giai đoạn sớm sau ghép thận
Nam, Đ. V., Mạnh, B. V., Việt, T. Q., Thu, N. T. M., Thu, N. T., Phượng, T. T., Chính, N. Đ., Tuấn, C. M., Công, V. T., Lợi, N. T., et al. (2024) · Journal of 108 - Clinical Medicine and Phamarcy · doi:10.52389/ydls.v19i6.2394
McGinn, R. N., Morrison, J., Bieze, M., & McCluskey, S. A. (2026) · Transplantation Reviews · doi:10.1016/j.trre.2026.101043
TRANSPLANTE RENAL NO PACIENTE DIABÉTICO COM DOENÇA RENAL CRÔNICA
Noronha, I. D. L., Mesquita, P. G. M., & Pestana, J. O. M. (2010) · Brazilian Journal of Transplantation · doi:10.53855/bjt.v13i3.240
3. TĂNG ĐƯỜNG HUYẾT SỚM SAU PHẪU THUẬT GHÉP THẬN
Huệ, P. V., & Dũng, N. T. (2024) · Tạp chí Y học Cộng đồng · doi:10.52163/yhc.v65icd9.1508
Nutrition Therapy in Kidney Transplantation
Yuniarti, H. (2025) · South Asian Research Journal of Medical Sciences · doi:10.36346/sarjms.2025.v07i03.002
Salinas, I. A. A., Ramírez, E. B., Suárez, A. P., Kavanagh, K., Brito, V. D. J. H., González, E. R., & Ruiz, J. R. V. (2026) · Ciencia Latina Revista Científica Multidisciplinar · doi:10.37811/cl_rcm.v10i2.23521
Dos Santos, Q., Hornum, M., Terrones-Campos, C., Crone, C. G., Wareham, N. E., Soeborg, A., Rasmussen, A., Gustafsson, F., Perch, M., Soerensen, S. S., et al. (2022) · doi:10.3389/ti.2022.10352.s001
dos Santos, Q., Leung, P., Thorball, C. W., Ledergerber, B., Fellay, J., MacPherson, C. R., Hornum, M., Terrones-Campos, C., Rasmussen, A., Gustafsson, F., et al. (2023) · doi:10.3389/fmolb.2023.1282412.s003
Approach to Medical Complications After Kidney Transplantation
Vella, J. P. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0008-0_8
Metadata
- Authors
- Chakkera, H. A., Weil, E. J., Castro, J., Heilman, R. L., Reddy, K. S., Mazur, M. J., Hamawi, K., Mulligan, D. C., Moss, A. A., Mekeel, K. L., Cosio, F. G., & Cook, C. B.
- Affiliations
- Mayo Clinic (US)
- National Institutes of Health (US)
- ORCID
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2009-04
- Volume
- 4
- Issue
- 4
- Pages
- 853-859
- ISSN
- 1555-9041 (ISSN-L)
- PMC
- PMC2666437
- OpenAlex
- W2083842417
- Cited by
- 124
- References
- 27
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 8 · 2023: 10 · 2022: 9 · 2021: 13 · 2020: 11 · 2019: 10 · 2018: 10 · 2017: 4 · 2016: 7 · 2015: 13 · 2014: 3 · 2013: 5 · 2012: 3
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Center for Research Resources (KL2RR024151)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- hyperglycemia, kidney transplantation, postoperative period, new-onset diabetes, insulin therapy, immunosuppression, hypoglycemia, short-acting insulin, long-acting insulin, hospitalization
- MeSH terms
- Adult, Blood Glucose, Female, Humans, Hyperglycemia, Hypoglycemic Agents, Inpatients, Insulin, Male, Middle Aged, Retrospective Studies, Risk Factors, Surgical Wound Infection, Time Factors, Prevalence, Kidney Transplantation, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.